Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer

This study has been withdrawn prior to enrollment.
Sponsor:
Information provided by (Responsible Party):
University of Pittsburgh
ClinicalTrials.gov Identifier:
NCT00845078
First received: February 13, 2009
Last updated: April 25, 2017
Last verified: February 2009

February 13, 2009
April 25, 2017
December 2008
Not Provided
Aesthetic breast scores [ Time Frame: preoperative, 1 month, 6 months, 12 months, 24 months ]
Same as current
Complete list of historical versions of study NCT00845078 on ClinicalTrials.gov Archive Site
  • Quality of life (SF36) [ Time Frame: preoperative, 1 month, 6 months, 12 months, 24 months ]
  • Patient Breast aesthetic perception (BR23) [ Time Frame: preoperative, 1 month, 6 months, 12 months, 24 months ]
Same as current
Not Provided
Not Provided
 
Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer
Prospective Outcomes After Reconstruction and Radiotherapy for Breast Cancer

This study examines the aesthetic outcomes of breast reconstruction after mastectomy for breast cancer in patients who require post-mastectomy radiation treatment. Patients will undergo autologous tissue breast reconstruction either in immediate fashion, prior to radiation treatment, or in delayed fashion, after radiation treatment. Both approaches are acceptable and are practiced clinically. this will be an observational prospective cohort study.

The investigators hypothesize that immediate autologous reconstruction patients who undergo subsequent radiation therapy have equivalent aesthetic outcome when compared to those in whom reconstruction is delayed until after radiation, with the additional benefit of avoiding the psychological side effects of breast amputation.

Neo-adjuvant or adjuvant chemo-radiation remains one of the pillars for breast cancer treatment. (1, 2) Administration of radiation before or after autologous soft tissue reconstruction has being shown to alter the aesthetics of the new breast. (3-7) Currently, the optimal timing for autologous breast reconstruction in patients who need postmastectomy radiotherapy remains in debate between surgeons. (8) Various studies have tried to address this problem. However, most of them have been retrospective studies (3, 7, 9) and the prospective ones have not have enough patients, have mixed population of patients or the radiation protocols have not been normalized. (5, 6, 10)

We hypothesize that immediate autologous reconstruction patients who undergo subsequent radiation therapy have equivalent aesthetic outcome when compared to those in whom reconstruction is delayed until after radiation, with the additional benefit of avoiding the psychological side effects of breast amputation.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample
Patients undergoing mastectomy and radiation for breast cancer, who desire breast reconstruction after mastectomy
  • Breast
  • Radiotherapy
  • Aesthetics
  • Treatment Outcome
  • Surgical Reconstruction
Not Provided
  • 1
    Immediate reconstruction followed by radiation therapy
  • 2
    Radiation therapy followed by delayed reconstruction

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Withdrawn
0
Not Provided
Not Provided

Inclusion Criteria:

  • Breast cancer requiring mastectomy and post-mastectomy radiation
  • Desire for breast reconstruction after mastectomy

Exclusion Criteria:

  • Inflammatory breast cancer
  • Age < 18 years old
  • No desire for breast reconstruction
  • Women without need for postmastectomy radiation
Sexes Eligible for Study: Female
18 Years to 70 Years   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
Not Provided
United States
 
NCT00845078
PRO07120002
No
Not Provided
Not Provided
Not Provided
University of Pittsburgh
University of Pittsburgh
Not Provided
Principal Investigator: Julio A Clavijo-Alvarez, MD University of Pittsburgh
Study Director: Michael L Gimbel, MD University of Pittsburgh
University of Pittsburgh
February 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP